ZEB1 and colorectal carcinoma: While ZEB1 was correlated with a worse prognosis and a higher number of larger and undifferentiated mesenchymal KRASG12D-colorectal carcinomas, it was associated with a better prognosis and fewer, smaller and more differentiated BRAFV600E primary colorectal tumors [17].